ERIN FALASCO: Open Payments
NPI 1669061156 · AVON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 14 payments from 10 companies in 2025. Trend: 2023 $229 · 2024 $108 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| SANOFI PASTEUR INC. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Exact Sciences Corporation | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: REXULTI, MOUNJARO, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, Auvelity, Cologuard Collection Kit, SPRAVATO, GVOKE HYPOPEN, M-M-R II.
Industry payments across OH — which companies pay providers there.
